Our team in Australia is looking for international collaborators to do a joint research towards scientific publication on psoriasis treatment using our controlled-release formulation. If you are interested, please send us an email to: [email protected] and we will give you details.
I suggest we do clinical studies with our composite liposomal psoriasis cream. This is a completely safe and very well studied formulation with the following advantages:
Our novel psoriasis cream is more effective than conventional remedies, completely natural, made with natural elements of plant origin, and specially designed to eliminate scaling, other aesthetic problems and the itching caused by dermatitis and psoriasis. It contains a novel composite liposomal technology, hence providing long-lasting effect (sustained-release) of right combination of vitamins, oils and other beneficial ingredients. Our psoriasis ointment is made by a novel, Patented technology (US Patent: US20100239521-A1) which is environment-friendly, hence considered to be "Green Technology". Some of our psoriasis cream characteristics are: • It is non-greasy; • It does not contain steroids; • It does not contain steroid-like molecules either, • Has no contra-indications; • It can be used by diabetic patients; • Unlike many psoriasis remedies, it does not contain cortisone and is supported by pregnant and lactating women as well as babies; …
If you have access to psoriasis patients in your present location we can publish the data in very high IF journals. Please note clinical studies here in Australia is very costly. Let me know if you have any questions.
I look forward to hearing from you.
--- Prof. M. R. Mozafari, AUSTRALASIAN NANOSCIENCE AND NANOTECHNOLOGY INITIATIVE (ANNI), 8054 Monash University LPO, Clayton, Victoria 3168, Australia. http://anni.com.au/ Emails: [email protected] & [email protected] Tel: +61 3 87538268 and +61 424339961 ------------------------------------------------------------------------------
Dear Prof. Mozafari,
Thanks for sharing your interesting research on psoriasis, which was my research ( long time ago in an overseas university), where I used Zn and some plant materials; worked very well; however, I did not continue this work.
After completing my PhD in Pharmaceutics (in-vitro pulmonary drug delivery) from Monash University (Parkville Campus), I changed my previous research directions.
Currently, I am investigating the lung delivery of various polymeric nanoparticulate drugs from dry powder inhaler formulations with controlled released profile.
I am teaching Pharmaceutics here at Queensland University of Technology and happy to contribute to your research especially the semisolid dosage forms i.e. creams/ointments/gels for psoriasis. I have vast experiences in formulating verious drugs in different formulations.
I dont have access in clinical trial (obviously expensive) experiments or psoriasis patients; however, I can contribute to the formulation development area.
Please let me know if you think that my contribution is significant to your research.
With regards,
Nazrul
Dear Nazrul,
Greetings and thank you for your positive message. Please accept my apology for getting back to you late (I just saw your message!).
Please find below our contact details. I suggest we set a mutually convenient time to discuss details of the mentioned collaboration.
Looking forward to receive your email.
Kind regards
--- Prof. M. R. Mozafari, AUSTRALASIAN NANOSCIENCE AND NANOTECHNOLOGY INITIATIVE (ANNI), 8054 Monash University LPO, Clayton, Victoria 3168, Australia. http://anni.com.au/ Emails: [email protected] & [email protected] Tel: +61 3 87538268 and +61 424339961
-----------------------------------------------------------------------------------------------------
- Badges
- Science topic
- Similar topics
- Human-Computer Interaction
- Collaboration